Evidence map›Paper›PMID 18292776›Full record

ReviewNature reviews. Cancer2008

Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer.

Akeila Bellahcène, Vincent Castronovo, Kalu U E Ogbureke, Larry W Fisher, Neal S Fedarko

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Cancer, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 246 papers.

0numbers the graph read from it
0cells of the map it votes in
246citing papers in PubMed
23.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

246 citing papers in PubMed, 443 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. International journal of molecular sciences · 2025
    Article
  17. Review
  18. Article
  19. Article
  20. Review

186 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Akeila BellahcèneMetastasis Research Laboratory, University of Liege, Tour de Pathologie, -1, Bât. B23, Sart Tilman via 4000 Liège, Belgium.
Vincent Castronovo
Kalu U E Ogbureke
Larry W Fisher
Neal S Fedarko
Augusta University · USJohns Hopkins University · USNational Institutes of Health · USUniversity of Liège · BE

Funding

BONE AND TOOTH MATRIX BIOCHEMISTRY AND METABOLISMZ01DE000074 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI FISHER, LARRY W · 1985 to 2008
$1.9M
Small integrin-binding proteins and tumor progressionR01CA113865 · NCI · JOHNS HOPKINS UNIVERSITY · PI FEDARKO, NEAL S · 2006 to 2008
$750k
Continuous Wave Electron Paramagnetic Resonance ImagingZ01BC010478 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHERUKURI, MURALI · 2003 to 2008
$732k
BONE SIALOPROTEIN AND BREAST CANCER METASTASISR21CA087311 · NCI · JOHNS HOPKINS UNIVERSITY · PI FEDARKO, NEAL S · 2001 to 2002
$245k
Intramural NIH HHS Z01 BC010478NCI NIH HHS R01 CA113865NCI NIH HHS R21 CA087311NCI NIH HHS R21CA87311PHS HHS K23 017791-01A1
6 · The paper itself

Abstract

Numerous components and pathways are involved in the complex interplay between cancer cells and their environment. The family of glycophosphoproteins comprising osteopontin, bone sialoprotein, dentin matrix protein 1, dentin sialophosphoprotein and matrix extracellular phosphoglycoprotein - small integrin-binding ligand N-linked glycoproteins (SIBLINGs) - are emerging as important players in many stages of cancer progression. From their detection in various human cancers to the demonstration of their key functional roles during malignant transformation, invasion and metastasis, the SIBLINGs are proteins with potential as diagnostic and prognostic tools, as well as new therapeutic targets.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsDisease ProgressionExtracellular Matrix ProteinsGlycoproteinsHumansIntegrinsLigandsModels, BiologicalNeoplasm MetastasisNeoplasmsNeovascularization, PathologicOsteopontinPhosphoproteinsPrognosisExtracellular Matrix ProteinsGlycoproteinsIntegrinsLigandsOsteopontinPhosphoproteins

Identifiers

PMID18292776
PMCPMC2484121
OpenAlexW2075267181

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.